KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Feb 09, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 08, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 07, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 04, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 03, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 02, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 01, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 31, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 28, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 27, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 26, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 25, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 24, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 21, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 20, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 19, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 18, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 14, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 13, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 12, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 11, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 10, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 07, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 06, 2022 $182.50 $182.50 $182.50 $182.50 0
Jan 05, 2022 $182.50 $182.50 $182.50 $182.50 0
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT